PSWC Young Scientist Satellite Conference 2017

Improving your skills for research in drug discovery, drug development and clinical usage


Track A: Fundamental & translational sciences and targeting sciences

Track B: Drug delivery formulation, manufacturing sciences

Track C: Regulatory science and science-based practice

YSC Final Programme
 

 

Friday 19 May

12:00-14:00

Arrival and Registration

14:00 - 16:00

 

Plenary Opening Ceremony

Lecture hall B:B8
Moderator: Rebecka Isaksson, Uppsala University

14:00 - 14:40 Welcome and opening of conference
Carmen Pena, FIP President
Tatsuro Irimura, FIP Chair Board of Pharmaceutical Sciences
Dominique Jordan, FIP Chair Board of Pharmaceutical Practice
Eva Åkesson, Vice-Chancellor of Uppsala University
Göran Alderborn, Dean at the Faculty of Pharmacy, Uppsala University

14:40 – 15:20 Plenary lecture
Kathy Giacomini, UCSF School of Pharmacy
Endogenous Roles of Drug Transporters

15:20 – 16:00 Plenary lecture
Thomas Lönngren, NDA Group AB
Global drug development from a regulatory and market access perspective - hurdles and opportunities

18:00– 21:00

Conference dinner and party at Norrlands student nation

Saturday 20 May

08:30 - 09:00

Poster mounting


 

 

 

Track A
Fundamental & translational sciences, and targeting sciences 


Track B
Drug delivery and formulation, manufacturing sciences
 

Track C
Regulatory sciences, and  science-based practice 

09:00– 09:45

Keynote

Room B:B22
Chair: Joseph Nicolazzo, Monash University
Co-chair: Rob van Wijk, Leiden University

Rada Savic, University of California San Francisco

Use of pharmacometrics and data science to combat global health problems

Keynote

Room B:B41
Chair: Stacey May, American Association of Pharmaceutical Scientists
Co-chair: Sayan Mitra, University of Sydney

Jan Kihlberg, Uppsala University

Drug discovery beyond the rule of 5 - How to design cell permeable ligands for difficult targets.

Keynote

Room B:B42
Chair: Bente Steffansen, University of Southern Denmark
Co-chair: Alexander Mammoo, AstraZeneca

Staffan Folestad, AstraZeneca R&D

Provision of innovative medicines  for the individual – Need for patient centric engineering in global health

10:00– 10:45

Workshop sessions

WS1 – part 1

Excellence in science

Elizabeth de LangeLeiden Academic Centre for Drug Research, the Netherlands

Room A1:104b

WS2 - part 1

Grant application

Krister Halldin, Uppsala University, Sweden

Room A1:112b 

WS3 - part 1

Patenting

Olivia Tolan and Pontus Skråmstadius, UU Innovation, Uppsala University, Sweden

Room A7:108

WS4 - part 1

Communicate science

Stacey May, American Association for Pharmaceutical Scientists, USA

Room A7:114

WS5 - part 1 

Entrepreneurship/Pitch your idea

 Moa Fransson, UU Innovation, Uppsala University, Sweden

Room A7:103

WS6 - part 1 

Regulatory framework

Pieter Stolk, Utrecht University, the Netherlands

Room A2:108a

 

WS7 - part 1

Pedagogical skills

Don Mager, University of Buffalo, USA

Room A2:122a

 

10:45– 11:15

Fika break

11:15– 12:00

Workshop sessions

WS1 – part 2

Excellence in science

Elizabeth de Lange, Leiden Academic Centre for Drug Research, the Netherlands 

Room A1:104b

WS2 – part 2

Grant application

Krister Halldin, Uppsala University, Sweden

Room A1:112b

WS3 – part 2

Patenting

Olivia Tolan and Pontus Skråmstadius, UU Innovation, Uppsala University, Sweden

Room A7:108

WS4 – part 2

Communicate science

Stacey May,American Association for Pharmaceutical Scientists, USA

Room A7:114

WS5 – part 2

Entrepreneurship/Pitch your idea

 Moa Fransson, UU Innovation, Uppsala University, Sweden

Room A7:103 

WS6 – part 2

Regulatory framework

Pieter Stolk, Utrecht University, the Netherlands

Room A2:108a

 

WS7 – part 2

Pedagogical skills

Don Mager, University of Buffalo, USA

Room A2:122a

 

12:00– 14:00

Lunch and poster viewing

13:30 - 14:00
Swedish Pharmaceutical Scoiety Award for Best Thesis in Galenical Pharmacy and Biopharmacy 2017 (GaBipriset)

Room B:B42

Award ceremony for, and lecture by, the recipient Dr. Shalini Singh

14:00– 15:30

Short communication

A1: Transporters and permeability 

Room B:B22

Chair: Elizabeth de Lange, Leiden University

Co-chair: Amal Kamal Abdel-Aziz, Ain Shams University

Short communication

B1: Modeling and synthesis 

Room B:B41

Chair: Anja Sandström, Uppsala University 

Co-chair: Irina Elena Antonescu, University of Southern Denmark

Short communication

C1: Regulatory, practice and manufacturing 

Room B:B42

Chair: Bente Steffansen, University of Southern Denmark

Co-chair: Maria Badal Tejedor,Research Insitutes of Sweden

15:30– 16:00

Fika break

16:00– 17:30

Short communication

A2: Intestinal absorption and antibiotic drug delivery 

Room B:B22

Chair: Pieter Stolk, Utrecht University

Co-chair: Amani Al-Hayali, Luleå University of Technology

Short communication

B2: Permeability and cells 

Room B:B41

Chair: Chamari Hettiarachchi, University of Colombo

Co-chair: Diego Romano Perinelli, University of Camerino

Short communication

A3: Drug delivery systems and pharmacokinetics 

Room B:B42

Chair: Anne Filppula, Uppsala University

Co-chair: Javier Morales, University of Chile

Sunday 21 May 

 

 

Track A

Fundamental & translational sciences, and targeting sciences

 

Track B 

Drug delivery and formulation, manufacturing sciences

 

Track C 

Regulatory sciences, and  science-based practice

09:00– 10:30

Plenary session

Lecture Hall B:B8
Moderator: Erik Melander, Uppsala University 

09:00 -  09:45 Plenary lecture
Helping shape the future of science and your career by serving your professional community
Joseph Nicolazzo, Monash University, Australia

09:45 - 10:30 Plenary lecture
Green Pharmacy from research to practice – taking responsibility for the environmental impact of medicines 

Eeva Teräsalmi, FIP Vice President, International Pharmaceutical Federation, Finland

10:30– 11:30

Fika break and poster viewing

11:30– 12:45

Plenary Closing Ceremony

Lecture Hall B:B8
Moderator: Caroline Alvebratt, Uppsala University 

11:30 – 12:15 Plenary lecture
Thinking beyond your thesis - pharmaceutical research & development for global health impact 
Steven Kern, Deputy Director of Quantitative Sciences, Bill and Melinda Gates Foundation, USA

12:15 – 12:45 Award ceremony and closing remarks

13:30

 

Bus departures to Stockholm (buses will be arranged for all participants)

Lunch 


 

Short Communication Sessions

Short communication session

Abstract No

Abstract title

Presenting Author

Drug delivery & targeting sciences and formulation & manufacturing sciences

A1: Transporters and permeability

1014

Transporter protein expression and localization in the human retinal pigment epithelium cell models

Laura Pelkonen, University of Eastern Finland, Finland

1015

How is mucus influencing on drug permeability in the PVPA?

Margherita Falavigna, University of Tromsø, Norway

1091

Effect of amino acid-based surfactants on Caco-2 cell permeability of macromolecular drugs

Diego Romano Perinelli, University of Camerino, Italy

1027

The use of Caco-2 cells to evaluate drug absorption from lipid-based formulations

Janneke Keemink, Uppsala University, Sweden

 

 

 

Drug delivery & targeting sciences and formulation & manufacturing sciences

A2: Intestinal absorption and antibiotic drug delivery

1085

Understanding the link between composition, structure formation and absorption of milk during digestion

Anna C. Pham, Monash Institute of Pharmaceutical Sciences,  Australia

1057

The effect of sparkling water on intraluminal formulation behaviour and systemic drug performance in man

Jens Van Den Abeele, KU Leuven, Belgium

1065

Examining the interaction of mesoporous silica particles with lipid digestion components

Kellie May, Monash Institute of Pharmaceutical Sciences, Australia

1046

In vitro lipolysis of drug loaded lipid-based formulations with solid-state characterization of drug precipitate

Linda C. Alskär, Uppsala University, Sweden

 

 

 

Drug delivery & targeting sciences and formulation & manufacturing sciences

A3: Drug delivery systems and pharmacokinetics

1043

Synthesis and characterization of PEGylated polyethyleneimine-entrapped gold nanoparticles by self-reduction

Shayesteh Amin, Shiraz University of Medical Sciences, Iran

1028

In Vitro Cytotoxicity and In Vivo Biodistribution of Simvastatin-loaded Lecithin/Chitosan Nanoparticles: Nasal Region as an Appealing Route for Brain Delivery

Adryana Clementino, National Council for Scienctific and Technological Development, Brazil

1093

Effects of silymarin on the pharmacokinetics of carbamazepine, oxcarbazepine, phenytoin and their main metabolites in rats

Ana Filipa Ferreira, University of Beira Interior, Portugal

1023

Pharmacokinetic evaluation of doxorubicin containing lipiodol-based emulsion and drug-eluting beads used in the treatment of intermediate hepatocellular carcinoma

Ilse Dubbelboer, Uppsala University, Sweden

 

 

 

Drug design, fundamental & translational sciences

B1: Modeling and synthesis

1011

Design, Synthesis and Testing of novel small molecule inhibitors of S-phase Kinase-Associated Protein 2

Ran Liu, University of Sydney, Australia

1089

Engineering of KR-12 derived from human host defence peptide LL-37 into stable, selective and potent antimicrobial drug lead

Taj Muhammad, Uppsala University, Sweden

1073

A semi-mechanistic PK/PD model to elucidate levofloxacin-induced killing and resistance development of Escherichia coli

Eva Goebgen, Institute of Pharmacy Germany

1069

Evaluating predictors of paclitaxel-associated peripheral neuropathy: a pharmacodynamic modelling approach

Francis Williams Ojara, Freie Universitaet Berlin, Germany

 

 

 

Drug design, fundamental & translational sciences

B2: Permeability and cells

1025

Measuring and modelling pH-profile of membrane permeability

Mare Oja, University of Tartu, Estonia

1038

Influence of lipophilicity and hydrogen bond formation on passive diffusion of small-molecule drugs across hexadecane-based artificial cell membranes

Ursula Thormann, Uppsala University, Sweden

1062

Factors affecting intestinal drug permeation in-vitro: rat intestinal tissue vs. artificial membrane

Danny Riethorst, KU Leuven, Belgium

1033

Attach or perish: culture morphology and causal factors for variable attachment properties of cryopreserved human hepatocytes

Magnus Ölander, Uppsala University, Sweden

 

No reserve.

 

Regulatory sciences and science based practice

C1: Regulatory, practice and manufacturing

1080

Pharmacists’ activities to minimise medication waste: an international survey

Charlotte Bekker, Utrecht University, Netherlands

1086

Digital Patient Support Tools for Improved Cardiovascular Disease Rehabilitatio

Alexander Mammoo, AstraZeneca, Sweden

1087

Impact of Different MIC Distribution in Determining Empirical Vancomycin Continuous Infusion Dosing in Critically Ill Population

Eko Setiawan, University of Surabaya, Indonesia

1070

Designing relevant test methods to characterise the disintegration properties of rapidly disintegrating tablets

Charlotte Bain, AstraZeneca, United Kingdom

 

 

 


Warning: Unknown: open(/var/lib/php/session/sess_4p4apn5iu9r8g287gec4h60n64, O_RDWR) failed: Permission denied (13) in Unknown on line 0

Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/var/lib/php/session) in Unknown on line 0